Perflutren

全氟丙烷

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug NamePerflutren
Drug Alias Name八氟丙烷perflutrenoperflutrenumDefinity VialPerflutren Lipid Microsphere +[11] 
ClassificationSmall molecules
Mechanisms of ActionUltrasonography enhancers
TargetsNot applicable
Therapy Area/IndicationsContrast agentsIschemic StrokeCardiovascular contrast agents +[27] 
Global Approved IndicationsContrast agentsCardiovascular contrast agents
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date1998/05/17
Country/TerritoryCanadaUnited StatesTaiwan +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSunnybrook Health Sciences CentreUniversity Of Southern CaliforniaGe Healthcare As +[8] 
Inactive CompaniesUniversity Of AlbertaSidney Kimmel Cancer Center At Thomas Jefferson UniversityCerevast Therapeutics Inc +[15] 
Active IndicationsContrast agentsCardiovascular contrast agentsAortic Aneurysm, Abdominal +[14] 
Inactive IndicationsIschemic StrokeST Elevation Myocardial InfarctionHeart Failure +[13] 

Other Information

ATC CodeV08DA04
Related LinksWikipediaDrugBankKEGG